Dreavent Capital
North America, Massachusetts, United States, Cambridge
Description
Dreavent Capital is an investment firm focused on Biotech Therapeutics companies.
Investor Profile
Dreavent Capital has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Series B rounds (top funding stages).
- Majority of deals are located in United States, Spain.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series A (50%)
- Series Unknown (33%)
- Series B (17%)
Country Focus
- United States (83%)
- Spain (17%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Clinical Trials
- Personal Health
- Precision Medicine
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.